Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Tumor Differentiation is Correlated with Estrogen Receptor Beta (ERβ) Expression but Not with Interleukin-6 (IL-6) Expression in Colorectal Carcinoma

The Indonesian Biomedical Journal · Vol. 16 No. 5 (2024) · hlm. 481–486

DOI
10.18585/inabj.v16i5.3324
ISSN
2085-3297, 2355-9179
Terbit
2024-10-28
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Colorectal carcinoma (CRC), the third most common malignant disease worldwide, is associated with estrogen receptor β (ERβ) and interleukin-6 (IL-6). ERβ is known to down-regulate IL-6 in prostate cancer, lung carcinoma, and CRC cell lines; however, its effect on human with CRC remains unclear. Therefore, this study was conducted to investigate the association between ERβ and IL-6 expressions with the clinicopathological features of CRC.METHODS: This was an analytic observational study using 40 paraffin blocks of CRC patients. ERβ and IL-6 expression was measured by immunohistochemistry (IHC) staining. The percentage of immunoreactive tumor cell per 1000 cells was manually recorded and tumor differentiation as well as tumor infiltration were determined. Tumor differentiation was graded according to the World Health Organization (WHO) 2010 criteria, while tumor infiltration was defined based on the American Joint Committee on Cancer (AJCC) 8th edition.RESULTS: Fifty percent of samples were well-differentiated CRC, and 57.5% samples were T3 infiltration tumors. IHC staining showed 35.5% of samples were positive for ERβ expression, while 70.86% were positive for IL-6 expression. There were negative correlation of ERβ expression with tumor differentiation (p=0.018; r=-0.371), but no correlation with tumor infiltration (p=0.836) were found. There was no correlation between ERβ expression with IL-6 expression (p=0.154).CONCLUSION: There is statistically significant correlation between tumor differentiation and ERβ expression, wherein improved tumor differentiation is linked to higher levels of positive ERβ expression. However, there is no discernible relationship between IL-6 and tumor differentiation. These findings suggest that while IL-6 was involved in the growth of the tumor, ERβ expression might have an impact on tumor differentiation.KEYWORDS: colorectal carcinoma, estrogen receptor beta, interleukin-6, cell differentiation

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 145 tautan kepenulisan bersama · 56 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Universitas Katolik Widya Mandala Surabaya
  • Sultan Agung Islamic University
  • Universitas Nahdlatul Ulama Surabaya
  • Universitas Jember
  • Bandung Institute of Technology
  • Universiti Sains Islam Malaysia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Yudy TjahjonoUniversitas Katolik Widya Mandala Surabaya4
Hendy WijayaUniversitas Katolik Widya Mandala Surabaya4
Sianty DewiUniversitas Katolik Widya Mandala Surabaya4
I Gede Putu Adhi WedhargaUniversitas Katolik Widya Mandala Surabaya3
Martha ErvinaUniversitas Katolik Widya Mandala Surabaya3
Irene Lingkan ParengkuanUniversitas Katolik Widya Mandala Surabaya3
Fedik Abdul RantamUniversitas Airlangga2
Suryo KuncorojaktiUniversitas Airlangga2
Erna Dwi WahyuniUniversitas Airlangga2
FX Himawan Haryanto JongUniversitas Katolik Widya Mandala Surabaya2
Retno Pudji RahayuUniversitas Airlangga1
Sri HernawatiUniversitas Jember1
Faurier Dzar Eljabbar LatiefBandung Institute of Technology1
Utari KresnoadiUniversitas Airlangga1
Amiyatun NainiUniversitas Jember1
Mohammad RubiantoUniversitas Airlangga1
Seno PradopoUniversitas Airlangga1
Sandy ChristionoSultan Agung Islamic University1
Islamy Rahma HutamiSultan Agung Islamic University1
Regilia Shinta MayangsariSultan Agung Islamic University1
Yayun Siti RochmahSultan Agung Islamic University1
Zurairah IbrahimUniversiti Sains Islam Malaysia1
Ah YusufUniversitas Airlangga1
Nur Hidayatul AiniyahUniversitas Nahdlatul Ulama Surabaya1
Chilyatiz ZahrohUniversitas Nahdlatul Ulama Surabaya1
Umdatus SolehaUniversitas Nahdlatul Ulama Surabaya1
Paul L TahaleleUniversitas Katolik Widya Mandala Surabaya1
Endang Isbandiati SoedionoUniversitas Katolik Widya Mandala Surabaya1
Adi Pramono HendrataUniversitas Katolik Widya Mandala Surabaya1
Sumi WijayaUniversitas Katolik Widya Mandala Surabaya1
Harmayetty HarmayettyUniversitas Airlangga1
Judi NurbaeniAfiliasi tidak diketahui1
Yuni Sufyanti AriefUniversitas Airlangga1
Puteri IndahUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Tumor Differentiation is Correlated with Estrogen Receptor Beta (ERβ) Expression but Not with Interleukin-6 (IL-6) Expression in Colorectal Carcinoma</dc:title><dc:creator>Imelda Theodora</dc:creator><dc:creator>I Ketut Sudiana</dc:creator><dc:creator>Vicky Sumarki Budipramana</dc:creator><dc:creator>Ferdinand Erwin</dc:creator><dc:creator>Sianty Dewi</dc:creator><dc:creator>Bernadette Dian Novita</dc:creator><dc:subject>colorectal cancer</dc:subject><dc:subject>estrogen receptor beta</dc:subject><dc:subject>interleukin-6</dc:subject><dc:subject>tumor differentiation</dc:subject><dc:subject>tumor infiltration</dc:subject><dc:subject>clinicopathological features</dc:subject><dc:subject>tumor cell proliferation</dc:subject><dc:description xml:lang="en">BACKGROUND: Colorectal carcinoma (CRC), the third most common malignant disease worldwide, is associated with estrogen receptor β (ERβ) and interleukin-6 (IL-6). ERβ is known to down-regulate IL-6 in prostate cancer, lung carcinoma, and CRC cell lines; however, its effect on human with CRC remains unclear. Therefore, this study was conducted to investigate the association between ERβ and IL-6 expressions with the clinicopathological features of CRC.METHODS: This was an analytic observational study using 40 paraffin blocks of CRC patients. ERβ and IL-6 expression was measured by immunohistochemistry (IHC) staining. The percentage of immunoreactive tumor cell per 1000 cells was manually recorded and tumor differentiation as well as tumor infiltration were determined. Tumor differentiation was graded according to the World Health Organization (WHO) 2010 criteria, while tumor infiltration was defined based on the American Joint Committee on Cancer (AJCC) 8th edition.RESULTS: Fifty percent of samples were well-differentiated CRC, and 57.5% samples were T3 infiltration tumors. IHC staining showed 35.5% of samples were positive for ERβ expression, while 70.86% were positive for IL-6 expression. There were negative correlation of ERβ expression with tumor differentiation (p=0.018; r=-0.371), but no correlation with tumor infiltration (p=0.836) were found. There was no correlation between ERβ expression with IL-6 expression (p=0.154).CONCLUSION: There is statistically significant correlation between tumor differentiation and ERβ expression, wherein improved tumor differentiation is linked to higher levels of positive ERβ expression. However, there is no discernible relationship between IL-6 and tumor differentiation. These findings suggest that while IL-6 was involved in the growth of the tumor, ERβ expression might have an impact on tumor differentiation.KEYWORDS: colorectal carcinoma, estrogen receptor beta, interleukin-6, cell differentiation</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-10-28</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v16i5.3324</dc:identifier><dc:identifier>10.18585/inabj.v16i5.3324</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 5 (2024); 481-486</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3324/739</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>